CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities:
Net income	$ 241,850	$ 118,722
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Stock-based compensation	251,716	96,228
(Gain) loss on strategic investments and marketable securities, net	(192,158)	42,306
Depreciation and amortization	30,745	12,844
Provision for bad debts and inventory	13,824	5,083
Deferred income taxes	(27,061)	(52,955)
Other noncash items	13,183	8,238
Change in assets and liabilities:
Receivables and contract assets	(226,759)	(186,614)
Inventory	(11,629)	(65,096)
Deferred revenue	56,720	103,386
Accounts payable, accrued and other liabilities	10,243	13,367
Other, net	(2,528)	(46,284)
Net cash provided by operating activities	158,146	49,225
Cash flows from investing activities:
Purchases of investments	(615,414)	(444,685)
Business acquisitions, net of cash acquired	(237,796)	(21,090)
Proceeds from call, maturity, and sale of investments	858,326	461,214
Proceeds from call, maturity, and sale of investments	(53,984)	(35,624)
Other, net	34	(512)
Net cash (used in) investing activities	(48,834)	(40,697)
Cash flows from financing activities:
Net proceeds from equity offering	0	94,705
Proceeds from options exercised	9,717	54,503
Income and payroll tax payments for net-settled stock awards	(22,325)	(104,076)
Net cash (used in) provided by financing activities	(12,608)	45,132
Effect of exchange rate changes on cash and cash equivalents	75	(1,201)
Net increase in cash and cash equivalents	96,779	52,459
Cash and cash equivalents and restricted cash, beginning of period	600,670	355,552
Cash and cash equivalents and restricted cash, end of period	$ 697,449	$ 408,011